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background: Blood pressure (BP) treatment reduces the incidence of heart failure hospitalizations (HF) in hypertensive (HTN) patients. However, 
not all HTN individuals manifest HF suggesting a variable impact of BP on the myocardium. We evaluated if high sensitivity troponin T (hsTnT), a 
marker of myocardial injury, identifies individuals at higher HF risk within narrow BP categories among 10416 individuals enrolled in the ARIC study.
methods: After excluding individuals with prevalent HF, incident HF events by SBP and hsTnT categories were calculated. Cox proportional hazard 
models were used to test the association between hsTnT and HF within various systolic BP categories after adjustment for covariates (table).
Results (Table): The mean age of the study population was 62.8 years (56% women). There were 1144 HF hospitalizations over a mean follow up 
of 11.1 years. For all SBP categories, the hazards for HF increased with increasing hsTnT levels, as did percentage of incident HF. Participants with 
elevated hsTnT in normal SBP ranges had numerically higher percentage of incident HF than those with high SBP and undetectable hsTnT.
conclusion: Risk of HF varies greatly within narrow SBP categories, and hsTnT identifies higher risk individuals. The majority of incident HF (n=604) 
occurred in individuals with SBP < 140 mmHg and measurable hsTnT suggesting that clinical trials should use biomarkers such as hsTnT to target a 
more informative patient population.
Association between hsTnT and incident HF across systolic BP categories
Incident HF
(1144/10416)
hsTnT (ng/L)
Undetectable 3-5 6-8 9-13 ≥14
<120 mm Hg 
incident HF/at risk (%)
52/1470 (3.5) 46/997 (4.6) 60/706 (8.5) 56/404 (13.9) 68/238 (28.6)
Model 1 HR (95% CI) ref 1.2 (0.8-1.9) 2.3 (1.5-3.3) 3.7 (2.4-5.6) 9.6(6.4-14.5)
Model 2 HR (95% CI) ref 1.4 (0.9-2.1) 2.2 (1.4-3.3) 3.1(2.0-4.8) 6.9(4.3-10.9)
120-129 mm Hg incident HF/at risk (%) 44/739 (6.0) 44/623 (7.1) 57/535 (10.7) 37/314 (11.8) 50/169 (29.6)
Model 1 HR (95% CI) ref 1.1 (0.7-1.7) 1.6 (1.5-2.4) 1.7 (1.1-2.8) 5.8 (3.7-9.2)
Model 2 HR (95% CI) ref 1.1 (0.7-1.7) 1.4 (0.9-2.2) 1.4 (0.9-2.4) 4.3 (2.6-7.1)
130-139 mm Hg incident HF/at risk (%) 34/537 (6.3) 43/455 (9.5) 52/381 (13.7) 37/233 (15.9) 54/162 (33.3)
Model 1 HR (95% CI) ref 1.5(0.9-2.3) 2.3(1. 5-3.6) 2.6 (1.6-4.3) 6.8 (4.2-10.8)
Model 2 HR (95% CI) ref 1.4 (0.8-2.2) 2.2 (1.4-3.6) 2.5 (1.5-4.2) 4.4 (2.6-7.4)
140-149 mm Hg incident HF/at risk (%) 22/330 (6.7) 37/284 (13.0) 35/238 (14.7) 37/195 (19.0) 44/132 (33.3)
Model 1 HR (95% CI) ref 1.9 (1.1-3.2) 2.2(1.3-3.8) 3.2 (1.8-5.5) 7.3 (4.2-12.7)
Model 2 HR (95% CI) ref 2.0(1.1-3.4) 1.9 (1.1-3.4) 2.7 (1.5-5.0) 5.8 (3.2-10.8)
150-159 mm Hg incident HF/at risk (%) 10/159 (6.3) 11/169 (6.5) 16/116 (13.8) 31/132 (23.5) 35/80 (43.8)
Model 1 HR (95% CI) ref 1.0 (0.4-2.5) 2.3 (1.0-5.2) 4.5 (2.1-9.5) 10.8 (5.1-22.6)
Model 2 HR (95% CI) ref 1.3 (0.5-3.2) 2.0 (0.8-4.9) 4.3 (1.9-9.9) 7.5 (3.2-18.0)
≥160 mm Hg
incident HF/at risk (%)
14/139 (10.1) 16/119 (13.5) 30/141 (21.3) 35/127 (27.6) 37/92 (40.2)
Model 1 HR (95% CI) ref 1.5(0.7-3.0) 2.3 (1.2-4.3) 3.4 (1.8-6.5) 7.7 (3.9-15.3)
Model 2 HR (95% CI) ref 1.4 (0.7-2.9) 1.8 (0.9-3.7) 2.8 (1.4-5.5) 5.0 (2.4-10.4)
Model 1: Adjusted for age, race and gender
Model 2: Adjusted for model 1 plus antihypertensive medication use, renal function (estimated glomerular filtration rate), diabetes, fasting glucose, total cholesterol/high-density lipoprotein cholesterol ratio, 
body mass index, current cigarette smoking, and previous CV disease status
hsTnT: high-sensitivity troponin T, ref: reference, HR: hazard ratio, CI: confidence interval
